Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet "Quad" HIV Regimen http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=1622859&highlight= It's extremely fast filing after 2nd pivotal trial result announced Sept. 19. Hopefully, they are not going to get RTF like Complera original filing: http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=1519760&highlight=